Boston Scientific Corp. (NYSE: BSX): Stifel reiterated a Buy rating with a $58 target price. The consensus target is $60.31, and Monday’s $53.80 close was up almost 6% on the day. Reports indicated the company is likely to win FDA approval for a new method of treating abnormal heartbeats.
Church & Dwight Co. Inc. (NYSE: CHD): Truist Financial upgraded the shares to Buy from Hold. The firm also lifted its $95 target price to $105, above the $99.61 consensus target. The stock closed on Monday at $94.43.
Ciena Corp. (NYSE: CIEN): Needham reiterated a Buy rating but lowered its target price to $50. The consensus target is $56.06, and Monday’s close was at $42.05.
Civitas Resources Inc. (NYSE: CIVI): Jefferies maintained its Buy rating, and its $100 target price is well above the consensus target of $87.86. Monday’s final trade was for $80.27 a share.
CrowdStrike Holdings Inc. (NASDAQ: CRWD): When Morgan Stanley lowered its Overweight rating to Equal Weight, its target price dropped to $167 from $178. The consensus target is $180.93. Monday’s closing share price was $144.03.
Denbury Inc. (NYSE: DEN): Jefferies downgraded the shares from Buy to Hold with a $91 target price. The consensus target is $96.78, and Monday’s close was at $90.28.
Emerson Electric Co. (NYSE: EMR): The Hold rating at Argus has been changed to Buy. The firm’s $110 target price compares with a consensus target of $107.38 and Monday’s close at $98.12.
Energizer Holdings Inc. (NYSE: ENR): Truist Financial cut its Buy rating to Hold and reduced its $40 target price to $35. The $37.50 consensus target also compares to Monday’s closing print of $34.30.
Essex Property Trust Inc. (NYSE: ESS): Though Truist Financial downgraded the stock to Hold from Buy, the analyst raised the $255 price target to $266. The consensus target is $249.11, and the stock closed on Monday at $238.07.
IDEX Corp. (NYSE: IEX): Oppenheimer reiterated an Outperform rating with a $245 target price. The consensus target is $233.41. The final trade on Monday was for $227.01 a share.
Kimco Realty Corp. (NYSE: KIM): Compass Point upgraded the stock to Buy from Neutral and has a $22 price target. The consensus target is $22.72. The stock closed at $18.78 on Monday.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
